[ad_1]
: Study reveals new COVID strain raises virus reproduction rate in UK
Read more
The doctor, said the SSa, have a history of allergic reactions to medicines such as trimethoprim with sulfamethoxazole, an antibiotic that fights urinary infections.
Its initial diagnosis is encephalomyelitis, which is described as a brief but severe attack of inflammation in the brain, usually from a viral infection.
The woman presented skin rash, seizures, decreased muscle strength and shortness of breath, in the
“The reaction was detected within the specific observation area of the vaccination cell in which the doctor received her vaccine“, indicated the SSa.
The @SHealth_mx studies the case of the doctor who presented a clinical reaction after the #Vaccination against # COVID-19
➡️ https://t.co/mx5OoQoxWj pic.twitter.com/Rn8YsD6VsR
– SALUD México (@SSalud_mx) January 2, 2021
Mexico is one of the first countries in the world to initiate vaccination against COVID-19, but so far it has only received about 53,000 doses of Pfizer-BioNTech drug, all applied to healthcare personnel.
The Government of Mexico, where the pandemic has left more than 1.4 million infections and more than 126,000 deaths, has opted for early access to the vaccine.
The country has contracts for pre-purchase of 34.4 million doses of Pfizer, 77.4 million of the British AstraZeneca, 35 million of the Chinese CanSino and 34.4 million of the Covax platform of the World Health Organization (WHO).
The Mexican president, Andrés Manuel López Obrador, promised that he will vaccinate against COVID-19 all health personnel by the end of January and “most” of its vulnerable population by April.
Mexico will receive another batch of Pfizer vaccines this Tuesday, in addition to the fact that next week the acquisition of 12 million doses for three months, from January to March, from China’s CanSino.
Meanwhile, the Ministry of Health (SSa) stated that follows the protocol of “Events supposedly attributable to vaccination and immunization” of the Federal Commission for the Protection against Sanitary Risks (Cofepris).
“The doctor is under observation and treatment by specialists in critical medicine to reduce the brain inflammation presented. Intensive specialized treatment will continue, “he concluded.
IT MAY INTEREST YOU
[ad_2]